Document Detail


AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes.
MedLine Citation:
PMID:  20816753     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
G-protein-coupled receptor (GPR) 119 is involved in glucose-stimulated insulin secretion (GSIS) and represents a promising target for the treatment of type 2 diabetes as it is highly expressed in pancreatic β-cells. Although a number of oral GPR119 agonists have been developed, their inability to adequately directly preserve β-cell function limits their effectiveness. Here, we evaluated the therapeutic potential of a novel small-molecule GPR119 agonist, AS1907417, which represents a modified form of a 2,4,6-tri-substituted pyrimidine core agonist, AS1269574, we previously identified. The exposure of HEK293 cells expressing human GPR119, NIT-1 cells expressing human insulin promoter, and the pancreatic β-cell line MIN-6-B1 to AS1907417, enhanced intracellular cAMP, GSIS, and human insulin promoter activity, respectively. In in vivo experiments involving fasted normal mice, a single dose of AS1907417 improved glucose tolerance, but did not affect plasma glucose or insulin levels. Twice-daily doses of AS1907417 for 4weeks in diabetic db/db, aged db/db mice, ob/ob mice, and Zucker diabetic fatty rats reduced hemoglobin A1c levels by 1.6%, 0.8%, 1.5%, and 0.9%, respectively. In db/db mice, AS1907417 improved plasma glucose, plasma insulin, pancreatic insulin content, lipid profiles, and increased pancreatic insulin and pancreatic and duodenal homeobox 1 (PDX-1) mRNA levels. These data demonstrate that novel GPR119 agonist AS1907417 not only effectively controls glucose levels, but also preserves pancreatic β-cell function. We therefore propose that AS1907417 represents a new type of antihyperglycemic agent with promising potential for the effective treatment of type 2 diabetes.
Authors:
Shigeru Yoshida; Hirotsugu Tanaka; Hiroyuki Oshima; Takao Yamazaki; Yasuhiro Yonetoku; Takahide Ohishi; Tetsuo Matsui; Masayuki Shibasaki
Related Documents :
18818553 - Dexamethasone base conserves hearing from electrode trauma-induced hearing loss.
10604043 - Studies on the euglycemic and hypolipidemic potentials of the novel indole analogue of ...
9761593 - Prenatal sulfur dioxide exposure induces changes in the behavior of adult male mice dur...
Publication Detail:
Type:  Journal Article     Date:  2010-09-15
Journal Detail:
Title:  Biochemical and biophysical research communications     Volume:  400     ISSN:  1090-2104     ISO Abbreviation:  Biochem. Biophys. Res. Commun.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-04     Completed Date:  2010-11-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372516     Medline TA:  Biochem Biophys Res Commun     Country:  United States    
Other Details:
Languages:  eng     Pagination:  745-51     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Affiliation:
Drug Discovery Research, Astellas Pharma Inc., Tsukuba, Ibaraki 305-8585, Japan. shigeru.yoshida@jp.astellas.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cyclic S-Oxides / chemistry,  pharmacology*,  therapeutic use
Cytoprotection*
Diabetes Mellitus, Experimental / drug therapy*
Diabetes Mellitus, Type 2 / drug therapy*
Glucose Tolerance Test
Humans
Hypoglycemic Agents / chemistry,  pharmacology*,  therapeutic use
Insulin / genetics,  secretion
Insulin-Secreting Cells / drug effects*,  secretion
Male
Mice
Mice, Inbred Strains
Promoter Regions, Genetic / drug effects
Pyrimidines / chemistry,  pharmacology*,  therapeutic use
Rats
Rats, Zucker
Receptors, G-Protein-Coupled / agonists*
Chemical
Reg. No./Substance:
0/AS 1907417; 0/Cyclic S-Oxides; 0/GPR119 protein, human; 0/Hypoglycemic Agents; 0/Pyrimidines; 0/Receptors, G-Protein-Coupled; 11061-68-0/Insulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  2-Methoxy-4-vinylphenol can induce cell cycle arrest by blocking the hyper-phosphorylation of retino...
Next Document:  Calcium and secondary CPK signaling in plants in response to herbivore attack.